Profile
Sumeet Ambarkhane formerly worked at LAVA Therapeutics NV, as Executive Medical Director from 2021 to 2022, MorphoSys AG, as Head-Medical & Clinical Strategy, and Alligator Bioscience AB, as Chief Medical Officer from 2022 to 2025.
Dr. Ambarkhane received his doctorate degree from King Edward Memorial Hospital.
Former positions of Sumeet Ambarkhane
| Companies | Position | End |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Chief Tech/Sci/R&D Officer | 2025-03-30 |
| LAVA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2021-12-31 |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Training of Sumeet Ambarkhane
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Alligator Bioscience AB
Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
King Edward Memorial Hospital
King Edward Memorial Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAVA Therapeutics NV
LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Sumeet Ambarkhane
















